Liver RNA was purified and subjected to quantitative PCR analysis (
supplementary material)
50 (link).
Psd3 mRNA was quantitated using the primer probe set Mm01351099_m1 (ThermoFisher Scientific). RNA transcript levels were normalized to total RNA levels using
Quant-iT RiboGreen RNA reagent (ThermoFisher Scientific)
51 (link).
For lipogenic and inflammatory gene expression, total RNA was sequenced on a
NextSeq500 sequencing instrument (Illumina) (
supplementary material).
Mancina R.M., Sasidharan K., Lindblom A., Wei Y., Ciociola E., Jamialahmadi O., Pingitore P., Andréasson A.C., Pellegrini G., Baselli G., Männistö V., Pihlajamäki J., Kärjä V., Grimaudo S., Marini I., Maggioni M., Becattini B., Tavaglione F., Dix C., Castaldo M., Klein S., Perelis M., Pattou F., Thuillier D., Raverdy V., Dongiovanni P., Fracanzani A.L., Stickel F., Hampe J., Buch S., Luukkonen P.K., Prati D., Yki-Järvinen H., Petta S., Xing C., Schafmayer C., Aigner E., Datz C., Lee R.G., Valenti L., Lindén D, & Romeo S. (2022). PSD3 downregulation confers protection against fatty liver disease. Nature Metabolism, 4(1), 60-75.